Ontology highlight
ABSTRACT:
SUBMITTER: Hoering A
PROVIDER: S-EPMC5705823 | biostudies-literature | 2017 Jun
REPOSITORIES: biostudies-literature
Hoering Antje A Durie Brian B Wang Hongwei H Crowley John J
Future oncology (London, England) 20170411 13
Unlike conventional cancer treatment, immuno-oncology therapies are commonly associated with delayed clinical benefit and durable responses, as seen with immuno-oncology therapies for multiple myeloma (MM). Therefore, a longer-term approach to immuno-oncology data assessment is required. Appropriate study designs, end points and statistical methods are essential for evaluating immuno-oncology therapies to assess treatment outcomes, and may better accommodate immuno-oncology clinical trial data. ...[more]